Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Teclison Ltd.
Teclison Ltd.
Eli Lilly and Company
Molecular Partners AG
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
Crinetics Pharmaceuticals Inc.
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
YourChoice Therapeutics, Inc.
Enterome
Chimeric Therapeutics
IDEAYA Biosciences
Eli Lilly and Company
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Tanabe Pharma America, Inc.
Perspective Therapeutics
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
BioXcel Therapeutics Inc
Phanes Therapeutics
Vyriad, Inc.
Hutchmed
PharmaMar
Hoffmann-La Roche
Hutchmed
Crinetics Pharmaceuticals Inc.
Purple Biotech Ltd.
Aminex Therapeutics, Inc.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
23andMe, Inc.
Hutchmed
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Shanghai Henlius Biotech
Ipsen
Novartis
Tarveda Therapeutics
Daiichi Sankyo
Ipsen
Arbutus Biopharma Corporation
Molecular Insight Pharmaceuticals, Inc.